Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
DTR, dynamic treatment regime(s)
NICE Technology Appraisal guidance (TA875 for semaglutide/Wegovy and TA664 for liraglutide/Saxenda) recommends these medications for weight management in adults with: A body mass index (BMI) of at least 35 kg/m and At least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or non-alcoholic fatty liver disease) For liraglutide (Saxenda), NICE TA664 specifies additional criteria including prediabetes (HbA1c 42-47 mmol/mol or fasting plasma glucose 5.5-6.9 mmol/L) or high risk of cardiovascular disease
Packed with vitamins like B12, B5, and a blend of B-Complex, alongside minerals like Copper and Zinc, it boosts energy, hydration, and stamina for an unforgettable night out
That may include therapy for obstructive sleep apnea, cognitive behavioral therapy for insomnia, GLP-1 medications when clinically indicated, or hormone replacement therapy for managing menopausal symptoms
